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fibrous dressing to act as a tissue guide for in situ wound
repair while releasing Ibuprofen to reduce inflammation in
wounds and reduce pain for patients on dressing changes.
Dissolving the acid form of Ibuprofen (from 1% to 10% by
weight) in the same solvent as 75% polylactide, 25% poly-
glycolide (PLGA) polymers gave uniformly loaded electro-
spun fibers which gave rapid release of drug within the first
8 h and then slower release over several days. Scaffolds with
10% Ibuprofen degraded within 6 days. The Ibuprofen
released from these scaffolds significantly reduced the
response of fibroblasts to major pro-inflammatory stimu-
lators. Fibroblast attachment and proliferation on scaffolds
was unaffected by the addition of 1–5% Ibuprofen. Scaffolds
loaded with 10% Ibuprofen initially showed reduced cell
attachment but this was restored by soaking scaffolds in
media for 24 h. In summary, addition of Ibuprofen to
electrospun biodegradable scaffolds can give acute protec-
tion of adjacent cells to inflammation while the scaffolds
provide an open 3D fibrous network to which cells can
attach and migrate. By 6 days, such scaffolds will have
completely dissolved into the wound bed obviating any
need for dressing removal.
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The incidence of chronic wounds is increasing with an aging
population in the western world. Many of these patients
have chronic leg ulcers, often associated with venous disease
(estimated to be between 1 and 2 per 1,000 population) and
at any one time 20% of people with an active leg ulceration
will have an open ulcer (Gottrup et al., 2002). Additionally
the incidence of diabetes is increasing and as many as 10–
20% of these patients will develop non-healing diabetic foot
ulcers (Jeffcoate and Harding, 2003). There are also patients
poorly mobile in hospital at risk of developing bed sores. For
all of these patients new approaches to accelerate healing and
reduce pain are badly needed.
Pain is a major problem for the majority of patients with
chronic ulcers (the exceptions are patients with diabetes and
spinal injuries who do not experience wound associated pain
because of nerve damage). Themajority of chronic ulcers are
managed in the community and from the point of view of
the patient the day-to-day problems are twofold—pain on
dressing changes and the failure of ulcers to heal. Patients
with chronic wounds often experience pain on dressing
changes (Noonan and Burge, 1998) and the removal of the
dressing itself can be associated with an inflammatory
reaction. The reasons why chronic wounds fail to heal are
several and interrelated—wounds are often poorly vascu-
larized and hypoxic, commonly inflammed, often infected
and as a consequence aggressive and resistant to healing.
The aim of this study is to tackle several of the problems
experienced in the chronic wound by developing rapidly
degrading electrospun scaffolds based on poly(D,L)-lactide-
co-glycolide (PLGA) copolymers. These will not only act as a
temporary tissue regeneration guide in the promotion of 2009 Wiley Periodicals, Inc.
new tissue formation but also to release the anti-
inflammatory Ibuprofen to reduce pain for the patients
and reduce the excessive inflammation of the wound bed
which can prevent healing.
Dressings designed to reduce pain and accelerate healing
are not new—occlusive dressings to achieve these ends were
first introduced in 1948 (Gilje, 1948). These allow more
rapid re-epithelialization by reducing scab formation, and
also decrease the chances of gauze or fibrous dressings
sticking to the wounds and causing re-injury upon dressing
removal (Hinman and Maibach, 1963). However, these
dressings still need to be removed. Pain relief in wound
healing is positive for the patient in many ways as pain
promotes psychological stress in patients (Christian et al.,
2006) while pain relief allows patients to bear compression
therapy, which is often beneficial in chronic wound healing
(Price et al., 2007, 2008). Unfortunately, systemic pain relief
has not proven very efficient in tackling chronic wound pain
as the pain relief from most medications lasts only minutes
or hours (Cardenas and Jensen, 2006) and there are concerns
about patients becoming addicted to painkillers.
Encouragingly recent studies have shown beneficial effects
on wound pain with the use of dressings that slowly release
Ibuprofen without compromising wound healing (Gottrup
et al., 2002; Jorgensen et al., 2006). A biodegradable dressing
that does not need to be removed would be highly desirable
for the treatment of this type of wound.
Additionally there are many thousands of patients a year
(usually young children) who suffer superficial scald
injuries. While these will usually heal well, if not infected,
pain management is an issue especially at dressing changes
which can be very traumatic for young children. A dressing
which releases a painkiller and degrades into the wound
bed and is open to exudate (which can be extensive in
partial thickness burns) would be valuable if the fibers of
this dressing also acted as tissue guides for the re-
epithelialization of these wounds.
We recently developed synthetic biodegradable electro-
spun scaffolds as substrates for tissue engineering of skin and
oral mucosa. These are based on PLGA random multiblock
copolymers as described in detail in Blackwood et al. (2008).
These materials are FDA approved. Extensive research
into the degradation of PLLA and PGA show these to be
hydrolyzed into lactic and glycolic acids, respectively. Also
the breakdown rate for these scaffolds both in vitro and in
vivo can be modulated by varying the ratio of glycolide to
lactide (Blackwood et al., 2008; Kim et al., 2003). We also
confirmed that these scaffolds supported cellular ingrowth
both when implanted cell free into the flanks of rats (to study
their rate of degradation) and when cultured human skin
cells were placed on them in vitro. Skin cells attached and
migrated along the scaffold fibers producing new collagen
over the space of a few days (Blackwood et al., 2008).
In this study we aimed to develop biodegradable scaffolds
for skin cell attachment and migration which also
incorporate Ibuprofen to reduce pain and wound bed
inflammation. The concept is that these dressings willCinitially release Ibuprofen but also act simultaneously as a
temporary tissue guide for skin regeneration over several
days, eventually degrading into the wound bed leaving skin
cells in place so there will be no need to remove these
dressings.
We report on the production of these Ibuprofen loaded
scaffolds and the effect of the released Ibuprofen on
inflammation induced in skin cells by TNF-a (chosen as an
example of a pro-inflammatory cytokine) and by a bacterial
lipopolysaccharide (LPS) chosen to represent one aspect
of bacterial contamination. We also show the rate of
degradation of these scaffolds in vitro and their ability to
support skin cell attachment and proliferation.Materials and Methods
Scaffold Synthesis and Characterization
Polymers
For this study three PLGA copolymers with different ratios
of lactide to glycolide 75:25 (Mw 66–107k), 50:50 (Mw 40–
75k), and a 1:1 blend of these two were used. All the PLGA
copolymers were purchased from Sigma–Aldrich. The
polymers were dissolved in dichloromethane (DCM) to
form solutions of suitable viscosities for electrospinning;
75:25 and 50:50 to form 20% and 25% (wt/wt) solutions,
respectively, and equal volumes of these solutions were used
to form the blend. Ibuprofen powder (Sigma–Aldrich)
was added to the polymer solutions in DCM to form
homogeneous mixtures (from 1% to 10wt% of Ibuprofen
added relative to the weight of the polymer).Electrospinning Conditions
Polymer solutions were loaded into 2mL syringes fitted with
blunt tipped stainless steel needles with an internal diameter
of 0.8mm (J&J, Fairlawn, NJ, USA). The solutions were
delivered at a constant feed rate of 3.5mL/h using a
programmable syringe pump (Aladdin 1000) and were
electrospun horizontally with an accelerating voltage of
15 kV supplied by a high voltage power supply (Branden-
burg, Alpha series III). Fibrous mats were collected on
aluminum foil sheets (18 cm 16 cm) wrapped around an
earthed aluminum rotating collector (rotating at 300 rpm)
20 cm from the tip of the needle. Jet formation/stability was
assisted by means of an aluminum focusing ring at a voltage
of 15 kV, 5mm behind the tip of the needle. Scaffolds were
produced in an air-conditioned room at 218C with a relative
humidity of 30%, followed by drying under vacuum at
room temperature for a minimum of 24 h. To analyze the
environmental effect (humidity and temperature) on
scaffold reproducibility, scaffolds were occasionally spun
in high humidity conditions (>85% relative humidity) and
not dried under vacuum.anto´n et al.: PLA/PGA Electrospun Scaffold for Tissue Regeneration 397
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Detection of Ibuprofen Release From Scaffolds by
UV/Vis Spectroscopy
The release of the Ibuprofen from the three scaffold types
(each loaded with 10% Ibuprofen) was monitored using
UV/Vis spectroscopy. A 25mg piece of scaffold was cut from
each scaffold produced and submerged in 12mL of pure
water, and left at room temperature. The intensity at 222 nm
was measured (the lmax of IBU) at various time points
up to 1 week and the values were compared with a
previously calculated Ibuprofen standard curve. Three
separate replicates of electrospun polymer loaded with
Ibuprofen were used to determine the average Ibuprofen
release profile.In Vitro Degradation of Scaffolds
Scaffolds with or without Ibuprofen were cut into 18mm
disks using a tissue punch and were sterilized by gently
spraying them with 70% EtOH and left to dry in a sterile
flow cabinet. Scaffolds were then immersed in 1mL of
Ringers solution with 100 IU/mL penicillin and 100mg/mL
streptomycin and incubated at 378C. To test the effect of
the pH on the degradation of the scaffold, they were placed
in Ringers solution at three different pHs (6, 7.4, and 8.5).
Samples of this solution were taken daily to monitor pH
changes. Physical changes in the scaffold mats were also
recorded daily by taking optical micrographs of the
scaffolds.Cell Response to Scaffolds in 2D and 3D Cultures
Culture of Normal Human Keratinocytes and Fibroblasts
Normal human fibroblasts were isolated and cultured as
described previously (Ralston et al., 1997). Passage 3–7
fibroblasts were used. Keratinocytes were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supplemen-
ted with 10% (v/v) fetal calf serum (FCS), 2mM glutamine,
0.625mg/mL amphotericin B, 100 IU/mL penicillin, and
100mg/mL streptomycin. Preparation of 3D tissue engi-
neered constructs either in Azowipe1 scaffolds (non-woven
viscose rayon microfiber scaffolds bonded with styrene
butadiene copolymer, Vernon-Carus, Chorley, UK) or
PLGA 75:25 scaffolds was performed as previously described
(Blackwood et al., 2008).Detection of Cellular Metabolic Activity Via
MTT-ESTA Assay
The effect of Ibuprofen (sodium salt or isomer mixture;
Sigma–Aldrich, Poole, UK) on cell metabolic activity was
studied by adding Ibuprofen directly onto the cells or by
examining its release from scaffolds both in monolayers
(2D) and in 3D scaffolds. For 2D analysis, 3 104 HDF cells/398 Biotechnology and Bioengineering, Vol. 105, No. 2, February 1, 2010well were cultured in 24 well plates until 80% confluent. For
3D analysis, 3 105 HDF cells/well were cultured in 12 well
plates in two layers of a viscose rayon scaffold for 48 h.
Scaffolds (with and without Ibuprofen) were placed above
cultured cells using co-culture inserts so that scaffolds were
immersed in the same media as the cells for 24 h but were
physically separated from the fibroblasts. Cellular metabolic
activity (in 2D or 3D) was assessed using MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide)
(Sigma–Aldrich, St Louis, MO). Briefly, cells were washed
three times in PBS, and then incubated with MTT solution
(0.5mg/mL MTT in PBS, 1 and 2mL per well of 24 and
12 well plates, respectively) for 1 h at 378C in a humidified
incubator (5% CO2/95% air). In healthy viable cells, MTT is
reduced to a purple colored formazan salt by the activity of
the mitochondrial enzyme succinyl dehydrogenase. After
60min, the solution was aspirated and the insoluble
intracellular formazan product was solubilized and released
from cells by adding iso-propanol (0.5mL per well of 24 well
plate or 1mL/cm2 cultured tissue) and incubated for 10min.
The optical density at 490 nm with a reference wavelength
of 620 was then measured using a plate reading spectro-
photometer.Visualization of Cells Grown Within Scaffolds by
Staining for Collagen Production
To analyze the effect of environmental spinning conditions
(humidity and temperature) on the physical structure of
the scaffolds and on cell growth, 3D cultures on PLGA
scaffolds electrospun under different conditions were tested
for collagen deposition. Collagen deposition on scaffold
fibers was analyzed as described in Blackwood et al. (2008).
Briefly, constructs were grown for 7 days then washed three
times in PBS and fixed in 4% formalin. Following three
washes with PBS the constructs were stained for collagen
deposition in a 0.1% solution of Sirius Red F3B (C.I. 35780,
Direct Red 80, Sigma–Aldrich) in saturated picric acid for
18 h. Afterward, the constructs were washed with water until
no more red coloring was eluted. Scaffolds stained with
picrosirius red were then photographed with a digital
camera.Investigation of the Anti-Inflammatory Effect of Ibuprofen
and Ibuprofen Loaded Scaffolds by Immunolabeling of
Fibroblasts for the Detection of NF-kB/p65 Activation
LPS from E. coli serotype O111:B4 (Sigma–Aldrich) at
100 ng/mL or TNF-a (Sigma–Aldrich) at 1,000U/mL was
used as a positive control for activation of NF-kB in
fibroblasts. In preliminary experiments, Ibuprofen (103
and 104M, sodium salt and isomer mixture; Sigma–
Aldrich, UK) was used to down regulate NF-kB activation.
Then the 10% Ibuprofen loaded PLGA scaffolds (75/25, 50/
50, and a 1:1 blend of these two) were examined. Negative
controls were produced by incubating cells in normal
DMEM. All experiments were performed in triplicate.
Following the Ibuprofen treatments, monolayers were
washed in PBS and the cells were fixed in 10% formalin
(500mL/well) for 30min. Cell monolayers were washed a
further three times in PBS, prior to cell permeabilization
with 0.1% Triton X100 for 20min. Subsequently, cells were
washed three times with PBS. Unreactive binding sites were
blocked by adding a 5% dried milk powder solution to each
well for 1 h. A further three washes in PBS were performed
prior to incubation with the first antibody solution. The
first antibody (rabbit polyclonal antihuman IgG NF-kB p65
C-20, Santa Cruz Biotechnology Inc., Santa Cruz, CA) was
added at a concentration of 1:100 in 1% PBS-dried milk
powder. Cells were incubated in the antibody solution at 48C
for 18 h. The cells were washed three more times in PBS.
Afterward, cells were incubated with biotinylated goat
antirabbit (1:1,000) (Vector Laboratories, Burlingame, CA)
in 1% PBS-milk powder. The cells were then washed a
further three times in PBS. Streptavidin-FITC (Vector
Laboratories) conjugate was then added to the wells at a
concentration of 1:100 in PBS. A further three washes in PBS
were performed. After this time, the fluorescent staining
were visualized using an AXON image express system (Axon
Instruments/Molecular Devices, Union City, CA). Briefly,
fluorescence micrographs of immunolabeled samples were
taken using epifluorescent illumination at lex 495 nm, lem
515 nm (for FITC visualization); lex 358 nm, lem 461 nm
(for DAPI visualization). DAPI fluorescence was used to
identify nuclear position. The boundary between nucleus
and cytoplasm was delimited by analysis software (ImageX-
press Console 1.0) using DAPI micrographs in a sample of at
least 100 cellular counts per visual field. Within the defined
region, the intensity of FITC (NF-kB/p65) labeling was used
to calculate activation for each micrograph and sample. The
calculation of NF-kB activation was performed manually
according to intracellular position, as previously described
in Moustafa et al., 2002 and Canto´n et al., 2007, where total
nuclei localization indicates full activation of NF-kB and the
absence of nuclear localization indicates inactive NF-kB. p65
labeling in both nuclei and cytosol was taken as partial
activation. The analysis of the micrographs was done in
triplicate.
For cells cultured in 3D scaffolds the methodologies
used were described in Sun et al. (2004). For investigation
of fibroblast attachment and migration on Ibuprofen
loaded scaffolds, this was examined by loading cells onto
scaffolds containing 0%, 2%, 5%, and 10% Ibuprofen
and culturing cells for 7 days prior to assessment of cell
viability using MTT ESTA. In these experiments some
samples of scaffolds were washed by soaking in media
for various periods of 1–48 h prior to cell addition as
indicated.Statistics
Student’s unpaired t-test was used to assess the significance
of differences between results.CResults
Scaffold Synthesis and Characterization
Development of Reproducible Spinning Conditions for the
Production of Electrospun Material With Ibuprofen
PLGA scaffolds were electrospun from DCM solutions
loaded with 1–10wt% of Ibuprofen relative to the polymer
to produce fibers in which the Ibuprofen was uniformly
dispersed (see Fig. 1A, D, and F). The presence of the acid
form of Ibuprofen did not significantly alter the appearance
of the fibrous scaffolds as shown in Figure 1. The acid form
was used as the sodium salt of Ibuprofen was insoluble in
solvents suitable for processing the polymer. The latter was
found to result in a heterogeneous dispersion of the drug in
the spinning solution, and on spinning the drug had a
tendency to come to the surface of the fibers due to the
electrostatic forces involved in the process (see Fig. 1B).
Fibers produced in this way have been shown to have a
rapid burst release when submerged in aqueous media
(Taepaiboon et al., 2006). Accordingly to achieve a more
sustained release, homogeneous solutions of the polymer
and Ibuprofen isomer mixture (acid form) were prepared in
DCM for all subsequent studies.
The concentrations of the various polymers and the
electrospinning parameters were as previously described by
us (Blackwood et al., 2008). Ibuprofen (1–10wt%, relative to
the polymer) was added and each solution was thoroughly
dissolved prior to spinning. For the 1:1 ‘‘blend’’ of polymers,
equal volumes of the solutions of PLGA 50/50 (with
Ibuprofen) and 75/25 (with Ibuprofen) were mixed.
The temperature and humidity of the environment
in which the electrospinning was performed strongly
influenced the physical properties of the scaffold. Due to
the rapid solvent evaporation of the spinning solution as the
ejected fiber dries, it becomes cooler than its surroundings
and water vapor condenses upon it. Spinning in humid
conditions produced scaffolds which cells contracted
independent of the cell type grown on them or the presence
or absence of serum in the medium (Fig. 2A). Here it can be
seen that after only a few days in culture with cells
(fibroblast, keratinocytes, and co-cultures of both), the
scaffolds underwent obvious physical modifications (con-
traction, loss of thickness, and the fibers merged together to
give a porous film-like morphology). However, vacuum
drying the scaffolds immediately after spinning, in order to
thoroughly remove any surface water, produced scaffolds
that were much more resistant to cell contraction as seen in
Figure 2B.Ibuprofen Release From the Scaffolds and
In Vitro Degradation of Scaffolds
The release of the Ibuprofen from the three scaffold
types (each containing 10% Ibuprofen) was monitored
using UV/Vis spectrometry. For each experiment, a piece ofanto´n et al.: PLA/PGA Electrospun Scaffold for Tissue Regeneration 399
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Figure 1. SEM images of electrospun PLGA fibers. A: 50/50 PLGA with 10wt% Ibuprofen. B: 50/50 PLGA with 10wt% Ibuprofen sodium salt. C: 50/50 PLGA without Ibuprofen.
D: 1:1 blend of 50/50 and 75/25 PLGA with 10wt% Ibuprofen. E: 1:1 blend of 50/50 and 75/25 PLGA without Ibuprofen. F: 75/25 PLGA with 10wt% Ibuprofen. G: 75/25 PLGA without
Ibuprofen. Scale bar¼ 50mm.scaffold of 25mg was cut and submerged in 12mL of pure
water. This corresponded to around 2.5mg of Ibuprofen per
sample. The release of Ibuprofen from the samples was
monitored with UV/Vis spectroscopy at 222 nm (the lmax of
Ibuprofen) at various time points and compared to a
calibrated standard curve. The release profiles for the three
scaffolds are shown in Figure 3A and B. Results shown are
means of three separate replicates of electrospun scaffold.
All the scaffolds showed similar overall behavior, with an
initial rapid release of drug during the first 5 h (as shown in
Fig. 3A and on an expanded scale in Fig. 3B). Both the PLGA
50:50 and the blend released approximately 15% of their
total Ibuprofen, and the 75:25 released approximately 4.5%
of its total Ibuprofen in the first 5 h. This initial rapid release
of Ibuprofen was then followed by a steady sustained release
over the following 7 days (as shown in Fig. 3A), by which
point none of the scaffolds had totally released the drug. By
the end of 7 days the amounts released into the 12mL of
water over this period were 3.5mmol for both the PLGA
50:50 and the blend of 75:25 and 1.6mmol for the PLGA
75:25. This corresponds to approximately 30% release for400 Biotechnology and Bioengineering, Vol. 105, No. 2, February 1, 2010the PLGA 50:50 and the blend of 75:25 and 50:50 and
approximately 15% for the PLGA 75:25.
Previous work within this group has demonstrated that
the higher the percentage of glycolide to lactide in the
copolymer, the faster the breakdown of the scaffolds both in
vivo and in vitro (Blackwood et al., 2008). The 50/50 scaffold
broke down very rapidly (within a week in vitro) compared
to those composed of 75% lactide and 25% glycolide
which took around 3 months. Thus initially we focused on
the 50/50 scaffold as the best candidate for an Ibuprofen
releasing dressing which would degrade into the wound
bed. However, the hydrolytic degradation of PLGA is acid
catalyzed and we hypothesized that the presence of
Ibuprofen (acidic) within the scaffold could have an effect
on the breakdown rate of the scaffold.
Accordingly we investigated the effect of including
Ibuprofen in the scaffolds on the in vitro degradation of
scaffolds with different ratios of lactide to glycolide (50/50,
75/25, and a 1:1 blend of 50/50 and 75/25). Also as it has
been reported that the pH in non-healing wounds can range
from acidic to basic (Dissemond et al., 2003), we mimicked
Figure 2. Effect of environmental conditions on electrospun PLGA 75:25 scaf-
folds. Sirius red staining of collagen deposition of human fibroblasts (F), keratinocytes
(K), and co-cultures of both (Fþ K) grown for 1 week (in serum or serum-free
conditions) in 75:25 PLGA scaffolds spun in different conditions. A: Scaffolds were
spun in high humidity (>85%). B: As for (A), but then immediately after spinning,
scaffolds were dried under high vacuum at room temperature for 24 h.
Figure 3. Ibuprofen release profiles for three PLGA scaffolds: 75/25 (&), 50/50
(~), and a 1:1 blend of these two (*) dosed with 10wt% Ibuprofen. The concentration
(in mmol) of Ibuprofen released into 12mL of water was measured by UV/Vis
spectroscopy at 222 nm at various time points for 1 week. Results shown are
meansSD of three replicate samples looking at release over A) 7 days or B) 5 hours.these variations in pH in vitro in Ringer’s solution to pH 6,
7.4, and 8.5. In Figure 4 we show optical micrographs of
some of the 75:25 scaffold fibers at times 0, 1, and 6 days with
and without Ibuprofen. Table I summarizes the degradation
data from these experiments.
To begin with, all the scaffolds looked similar (with fibers
ranging from 2 to 5mm) whether scaffolds contained
Ibuprofen or not (Fig. 4). However, by day 6 the scaffolds
carrying Ibuprofen had lost all structural integrity. In
contrast the PLGA scaffolds (irrespective of the glycolide
content) without Ibuprofen maintained similar appearances
to those seen at day 0 (Fig. 4 and Table I).
This degradation was also independent of the initial pH of
the Ringer’s solution which did not change significantly
from the pH of 4–5 seen in the Ringer’s solution around the
scaffold at day 1. This did not change significantly over
6 days of the experiment (Table I).
As summarized in Table I the content of glycolide was a
key factor in speeding up the rate of degradation of the
fibers. The PLGA 50/50 scaffold had the fastest rate of
degradation with Ibuprofen present, indeed by day 1 the
physical structure of the Ibuprofen 50/50 scaffold
showed some merging of fibers (as shown in Fig. 4C and
summarized in Table I).CCell Response to Scaffolds
Cytotoxic and Anti-Inflammatory Responses of
Cells to Ibuprofen
Initially it was necessary to determine which concentrations
of Ibuprofen would be anti-inflammatory without being
cytotoxic for cells. Accordingly both the Ibuprofen sodium
salt and an isomer mixture of Ibuprofen (acid form) were
tested for their effects on viability of fibroblasts (results
summarized in Table II). Both forms of Ibuprofen
performed similarly, with cells tolerating concentrations
of Ibuprofen up to 103M (P< 0.05) but showing a
cytotoxic response at concentrations of 102M. For future
studies the concentrations of Ibuprofen investigated did not
exceed 103M.
We next examined the effects of Ibuprofen on LPS and
TNF induced NF-kB activation in fibroblasts (Figs. 5 and 6).anto´n et al.: PLA/PGA Electrospun Scaffold for Tissue Regeneration 401
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Figure 4. In vitro degradation of PLGA 75:25 scaffold in Ringer’s solution over
time. Optical micrographs of scaffolds with 10wt% Ibuprofen on the right-hand side
(A), (C), and (E) at days 0, 1, and 6 of incubation in Ringers solution. Scaffolds without
Ibuprofen on the left-hand side (B), (D), and (F). Scale bar¼ 100mm.
Table II. Effect of NaIbu and Ibuprofen isomer mixture on HDF viability
(MTT-ESTA assay).
Treatment





Control 100 16.43 100 16.43
106 102.17 17.71 109.43 15.53
105 100.43 18.55 111.80 13.19
104 98.21 14.04 108.56 15.71
103 90.33 11.70 101.11 18.30
102 38.25 5.79 P< 0.05 7.20 2.47 P< 0.05
The effect of 24 h exposure to Ibuprofen on human fibroblast viability
was assessed using the MTT-ESTA assay. Results shown are means SEM
of triplicate wells. Values differing from controls are indicated as P< 0.05.Concentrations of Ibuprofen of 104 and 103M—both the
Ibuprofen salt and the Ibuprofen isomer mix—were capable
of significantly reducing the response to LPS and TNF-a as
illustrated in Figure 5 and quantitative data is shown in
Figure 6. In these experiments LPS and TNF-a produced
80% activation of NF-kB. While the inhibitory effects of
Ibuprofen were small they were clearly significant against
these major pro-inflammatory stimulators.Table I. Effect of Ibuprofen and pH on in vitro degradation of PLGA
scaffolds.
Day Polymer
Extent of visible degradation
Control scaffolds þIbuprofen scaffolds
pH 6 pH 7.4 pH 8.5 pH 6 pH 7.4 pH 8.5
0 50:50 0 0 0 0 0 0
75:25 0 0 0 0 0 0
1:1 of above 0 0 0 0 0 0
1 50:50 0 0 0 þ þ þ
75:25 0 0 0 þ þ þ
1:1 of above 0 0 0 þ þ þ
6 50:50 0 0 0 þþ þþ þþ
75:25 0 0 0 þþ þþ þþ
1:1 of above 0 0 0 þþ þþ þþ
Visible degradation scored as none¼ 0, some þ or extensive þþ.
402 Biotechnology and Bioengineering, Vol. 105, No. 2, February 1, 2010Cytotoxic and Anti-Inflammatory Responses of
Cells to Ibuprofen Scaffolds
The next stage of experimentation was to place PLLA–PGA
scaffolds both unloaded and loaded with Ibuprofen above
cultures of fibroblasts in 3D scaffolds. The effect of the PLGA
scaffolds on cell viability and on the response of cells to pro-
inflammatory stimulation was then investigated. Addition-
ally we examined the loaded scaffolds in two ways. Some
were deliberately left unwashed so that any initial burst
release of Ibuprofen would be obtained in these experi-
ments. Others were vigorously washed in 70% EtOH and
then washed three times in PBS to remove any loosely bound
Ibuprofen.
There was no significant effect of the washed and
unwashed scaffolds on the viability of the fibroblast
monolayers placed under these scaffolds irrespective of
whether the scaffolds were loaded with 10% Ibuprofen or
not (results not shown).
One of the implications of this work is that any initial
burst release of Ibuprofen from the scaffolds does not appear
to be high enough to adversely affect adjacent cellular
viability to any significant degree. Calculations of the
maximum release of Ibuprofen from an 18mm disk
(approximately 6mg in weight) of PLLA–PGA into the
1mL of media over 24 h gave a theoretical maximum of
0.4mM (as derived from Materials and Methods Section)
assuming approximately 15% release of the 10% Ibuprofen
loaded into the scaffolds.
With respect to the anti-inflammatory effects of
Ibuprofen, incubation of 2D monolayers of fibroblasts with
the scaffolds containing the acid form of Ibuprofen
significantly reduced LPS stimulated NF-kB translocation
in all cases (P< 0.05) (Fig. 7). The inhibition observed with
the three different scaffolds was not significantly different,
and comparable to that observed when cells were incubated
with Ibuprofen at 104M (an isomer mix) as shown in
Figure 6 (previous experiments had shown that cells
responded similarly to both the sodium salt or the acid
form of Ibuprofen). Therefore it appears that 10%
Figure 5. NFkB immunolabeling of 2D HDF cultures after treatment with TNF-a,
LPS, and Ibuprofen. Immunofluorescent labeling of human fibroblasts for the p65
subunit of NF-kB, demonstrating relative transcription factor activity. a: Control
unstimulated cells. b: LPS (100 ng/mL) stimulated cells. c: TNF-a (1,000 U/mL) stimu-
lated cells. d: LPS (100 ng/mL1) plus Ibuprofen (103M) stimulated cells. e: TNF-a
(1,000 U/mL) and Ibuprofen (103M) stimulated cells. f: LPS (100 ng/mL) and Ibuprofen
sodium salt (104M) stimulated cells. g: TNF-a (1,000 U/mL) and Ibuprofen sodium salt
(104M) stimulated cells.Ibuprofen loaded into scaffolds was released from the
scaffolds in concentrations appropriate to inhibit inflam-
matory signaling in fibroblasts.
We next examined the effect of the scaffolds containing
Ibuprofen on cells cultured in 3D. Example images of the
appearance of these cells in 3D are shown in Figure 8. While
it is technically challenging to estimate NF-kB activation
using the p65 translocation in 3D, two points could be noted
from this study. Firstly there was less activation of the cells
with LPS in 3D than 2D (as has been reported from this
and other laboratories cells often cope better with insults
when in 3D rather than 2D (Sun et al., 2006)) and secondly
the 10% Ibuprofen scaffolds were capable of reducing the
LPS activation of NF-kB in these cells in 3D.CAbility of Ibuprofen Loaded Scaffolds to Support Cell
Attachment and Proliferation
Finally a comparison of fibroblast attachment and pro-
liferation on the scaffolds showed that fibroblasts attached
and proliferated on scaffolds loaded with 1, 2, and 5wt% of
Ibuprofen as well as on non-loaded scaffolds (Fig. 9A).
However, loading of scaffolds with 10% Ibuprofen did
reduce initial cell attachment but this could be partially (see
Fig. 9A) or fully (see Fig. 9B) restored to control levels by
washing the scaffolds for 24 h (consistent with scaffolds
releasing some of their Ibuprofen).
This shows that the Ibuprofen loaded fibers remain
capable of providing a substrate for these cells to attach and
migrate on.Discussion
The aim of this study was to develop a biodegradable
electrospun scaffold as a wound dressing capable of both
providing a temporary guide for cell migration, i.e., to act as
a tissue regeneration scaffold, and also to deliver sufficient
anti-inflammatory agent to help cells cope with the stresses
of an inflammatory wound bed while providing pain relief
for the patient.
We report on a simple methodology for the loading of
Ibuprofen into scaffolds which then release the Ibuprofen
over several days (with most rapid release in the first 5 h).
The levels of Ibuprofen being released are sufficient to
reduce the response of cells to major pro-inflammatory
cytokines without compromising the basic ability of the
scaffolds to act as substitute dermal scaffolds for the
attachment and migration of human dermal fibroblasts.
Thus the main objectives of this work were achieved and
these will now be discussed in detail before looking at the
next steps that must be undertaken to evaluate these
dressings for wound healing purposes.
The first challenge was to obtain reproducible spinning
conditions for the production of the electrospun material.
There are many factors involved in the electrospinning
process and their effect on scaffolds fiber diameter and pore
size is still being investigated empirically. The key variables
are solution viscosity, surface tension, and viscoelasticity of
the spinning solution. These are directly related to the
concentration and molecular weight of the polymer, as well
as the solvent used. The dielectric properties of the solution
also play a key role (Kowalczyk et al., 2008; Mitchell and
Sanders, 2006; Thompson et al., 2007). In this study we
sought to maintain several key parameters of the spinning
process, specifically the voltage, collector type and rotation
speed, the distance between the needle and the collector, the
solution feed rate, and the solution viscosity.
Another source of variation in electrospinning which is
perhaps not well documented is that once the polymer is in
solution it can change or degrade on storage and the same
concentration of polymer does not always yield a solutionanto´n et al.: PLA/PGA Electrospun Scaffold for Tissue Regeneration 403
Biotechnology and Bioengineering
Figure 6. Anti-inflammatory effect of Ibuprofen on HDF cells assessed by NFkB immunolabeling. Effect of (a) Ibuprofen and (b) Ibuprofen sodium salt on NFkB inflammatory
signaling. Human fibroblasts were incubated with media or Ibuprofen compounds (104 to 103M) for 15min before stimulation with LPS (100 ng/mL, open bars) or TNF-a
(1,000 U/mL, diagonal striped bars), or Ibuprofen compounds alone (filled bars) for 90min. Inflammatory signaling was determined using intracellular localization of NFkB. Key:
P< 0.001 compared to LPS alone, #P< 0.05, ##P< 0.001 compared to TNF-a alone.with the same viscosity. Thus the molecular weight of
the polymer will decrease rapidly over time (particularly
the 50/50 PLGA). Therefore, in this study fresh polymer
was used for spinning and the molecular weight was
checked regularly using gel permeation chromatography.
(We did not in this study investigate whether the stored
polymers achieved equilibrium on storage and whether
the stored polymers would then give predictable
scaffolds. This is something worth investigating for the404 Biotechnology and Bioengineering, Vol. 105, No. 2, February 1, 2010future in order to obtain reproducible conditions for
electrospinning.)
However, despite all of these precautions, considerable
variability was seen in the initial production of scaffolds.
It rapidly became clear that variability occurred when
spinning took place in environments of high temperature
and variable humidity. The most reproducible scaffolds
were those produced in a dry, air-conditioned room
(relative humidity 30%, temperature 218C). These
Figure 7. Effect of Ibuprofen loaded scaffolds on TNF-a and LPS stimulated NFkB activation in fibroblasts. Nuclear translocation of the pro-inflammatory transcription factor
NFkB was examined as illustrated in photos (a)–(e). In (a) and quantified in (b) for 2D cultures of fibroblasts exposed to Ibuprofen releasing scaffolds. In (a) control unstimulated
fibroblasts are shown. (b) LPS (100 ng/mL) stimulated fibroblasts (2 h exposure). (c) Cells exposed to LPS (100 ng/mL) for 2 h after pre-incubation with PLA/PGA Ibuprofen scaffolds
for 24 h. In (c) the scaffold was a 50/50 blend of 75/25 and 50/50 PLA/PGA loaded with Ibuprofen. (d) LPS (100 ng/mL) stimulated fibroblasts exposed to 75/25 PLA/PGA loaded with
Ibuprofen. (e) shows LPS (100 ng/mL) stimulated fibroblasts exposed to 50/50 PLA/PGA loaded with Ibuprofen. Cells were also directly exposed to Ibuprofen at 104M (an isomer
mix) as a positive control (referred to as Ibuprofen). Quantification of nuclear translocation of NFkB is shown for these fibroblasts in the histograms beneath in (b) for cells under
non-stimulated conditions (where the percentage of NFkB in the nucleus did not exceed 5%) and for cells stimulated with LPS (100 ng/mL) for 2 h after pre-incubation with PLA/PGA
ibuprofen scaffolds for 24 h. Results shown are meansþ SEM of triplicate cultures and statistical significance is indicated as P< 0.05, P< 0.001.scaffolds were then dried under vacuum for a minimum of
24 h and stored at 48C in sealed bags. Screening all of the
scaffolds with SEM showed that these were as expected and
identical to batches produced under similar conditions.
We do not claim to have resolved the issue of
reproducibility for electrospinning. This remains a major
challenge but our experience suggests that temperature and
particularly humidity need to be controlled and that the
development of electrospinning rigs which take both intoCaccount is needed for reproducible scale-up of electrospun
scaffold production.
The methodology for loading Ibuprofen into the scaffolds
was very simple. The acid form of Ibuprofen could be
dissolved in the same solvent as the PLGA polymer (DCM)
and this gave homogeneous distribution of Ibuprofen
through the scaffold fibers. In contrast the sodium salts did
not dissolve in DCM and produced very irregular scaffolds
in which the release of drug was much less predictable. Thusanto´n et al.: PLA/PGA Electrospun Scaffold for Tissue Regeneration 405
Biotechnology and Bioengineering
Figure 8. NFkB immunolabeling of 3D HDF cultures after treatment with LPS and Ibuprofen scaffolds. Fibroblasts were cultured in a 3D Azowipe scaffold (details as in
Materials and Methods Section) and exposed to Ibuprofen loaded scaffolds. Immunofluorescent labeling of cells for the p65 subunit of NF-kB was used to demonstrate the
relative transcription factor activity. a: Control unstimulated cells. b: HDF stimulated with LPS (100 ng/mL) for 2 h. c: HDF stimulated with LPS (100 ng/mL) for 2 h after pre-incubation
with a 50/50 blend of 75/25 and 50/50 PLA/PGA Ibuprofen scaffolds for 24 h. d: HDF stimulated with LPS (100 ng/mL) for 2 h after pre-incubation with 75/25 PLA/PGA Ibuprofen
scaffolds. e: HDF stimulated with LPS (100 ng/mL) for 2 h after pre-incubation with 50/50 PLA/PGA Ibuprofen scaffolds.the inference is clear—drugs which can be dissolved in the
organic solvent of the polymer can be directly spun into the
scaffold fibers. Further work is in progress to check if other
drugs can be loaded into scaffolds in a similar manner but
this seems to present a simple approach to drug loading into
scaffolds obviating the need for more complex approaches.
The next question was whether the scaffolds would release
sufficient Ibuprofen to be of value to the patient (with
respect to pain perception) and with respect to helping cells
in the wound bed cope with inflammation. This study
shows that approximately 30% of the Ibuprofen loaded was
released from the PLGA 50:50 and 75:25/50:50 blend
scaffold fibers over 7 days, while 15% of the Ibuprofen was406 Biotechnology and Bioengineering, Vol. 105, No. 2, February 1, 2010released from 75:25. It is probable that the reduced release of
Ibuprofen from 75:25 is due to the slower breakdown of
scaffold structure compared to the 50:50 and the 75:25/
blend, even if this was not visibly evident. Additionally, the
incorporation of Ibuprofen accelerated fiber breakdown as
can be seen from Table II. We were able to confirm that the
concentration of Ibuprofen being released was sufficient
to attenuate the inflammatory response of fibroblasts to a
major pro-inflammatory cytokine, TNF-a, and to LPS
which would normally be derived from bacteria.
The final question was whether the scaffolds, which
were releasing Ibuprofen, still retained the ability to act as
scaffolds for skin cell attachment, migration, and prolifera-
Figure 9. Culture of fibroblasts on Ibuprofen loaded scaffolds. Fibroblasts
were cultured on control and Ibuprofen loaded PLGA 75:25 scaffolds (details as in
Materials andMethods Section) for 48 h (a) or 7 days (b) and their survival assessed by
MTT-ESTA assay. In (A) scaffolds were loaded with 0%, 1%, 2%, 5%, or 10% Ibuprofen
and then washed by immersion in media for 0, 24, or 48 h before cells were cultured on
them. In (B) scaffolds were either unloaded or loaded with 10% Ibuprofen and then
washed for 0, 1, or 24 h prior to cell culture. Results shown are meansþSD of triplicate
wells of cells.tion. This was investigated by looking at the attachment and
proliferation of human dermal fibroblasts on the scaffolds.
Results showed that while cell attachment to the freshly
prepared Ibuprofen loaded scaffolds was reduced at the
highest concentration of Ibuprofen loaded (10%) this was
restored once scaffolds had soaked in PBS for 24 h after
sterilization, when cell attachment increased back to levels
seen in the control unloaded scaffolds. This showed that
loading Ibuprofen into the scaffolds did not change their
basic ability to act as fibers for skin cell attachment and
migration which is encouraging for developing these fibers
as tissue guides for wound healing applications.
With respect to wound healing, a certain level of
inflammation accelerates wound healing as the release of
pro-inflammatory cytokines attracts cells into the wound
area—the converse is also true and too high a level of
inflammation can retard wound healing (Diegelmann and
Evans, 2004; Werner and Grose, 2003). This is certainly
thought to be the case in many aggressive chronic wounds
where months and even years of matrix metalloprotease
activity and secretion of pro-inflammatory cytokines createCwound bed environments in which the normal skin cells at
the perimeter of the wound fail to survive if they migrate
into the wound bed. Thus cells capable of wound healing
fail to move into these aggressive wound beds as the
extracellular matrix present is under constant degradation
due to matrix metalloproteases (e.g., Armstrong and Jude,
2002; Cook et al., 2000).
We hypothesize that the introduction of a synthetic
scaffold of fibers capable of supporting normal skin cell
attachment and migration and proliferation will help to
accelerate wound healing by providing an immediate
alternative substrate for unaffected skin cells at the wound
margins to migrate across. The simultaneous release of an
anti-inflammatory from these fibers will hopefully calm
down these aggressive inflamed wound beds.
Conclusions
We present a conceptually simple approach to a wound
healing dressing which provides a temporary substrate for
the cells in the wound bed to migrate along while delivering
Ibuprofen as an anti-inflammatory agent and pain reliever.
This scaffold degrades in 6 days avoiding the need to remove
this dressing. The flexibility of the electrospinning technique
lends itself to combining the production of fibers to support
cell attachment and migration with simultaneous drug
release.
The number of chronic non-healing wounds where this
could be of benefit are enormous and increasing with an
aging population. Such dressings could also be of value in
treating superficial burns and scalds where approaches to
simultaneously manage pain and accelerate re-epithelializa-
tion are also needed.
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